What are the major opportunities in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market? What are the strategies for the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

For detailed insights on the major opportunities and strategies in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market, Read More

How does the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market relate to the overall economy and other similar markets?

For detailed insights on Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market growth? SWOT analysis of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market.

For detailed insights on the key dynamics influencing the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market growth and SWOT analysis of the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors industry, Read More

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report 2026

Name: Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Invokana, Jardiance, Farxiga Or Forxiga, Suglat), By Route Of Administration (Oral Route, Other Route Of Administration), By End User (Hospitals, Homecare Settings, Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

• Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market size has reached to $10.96 billion in 2025

• Expected to grow to $16.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%

• Growth Driver: Rising Diabetes Prevalence Boosts Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Market Growth

• Market Trend: Innovations In SGLT2 Inhibitors For Enhanced Diabetes And Heart Failure Management

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of medications used to treat type 2 diabetes by blocking the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion in urine. This helps lower blood glucose levels and can also contribute to weight loss and reduced blood pressure. They have additional cardiovascular and renal benefits, making them valuable in managing diabetic complications.

The main types of sodium glucose cotransporter 2 (SGLT 2) inhibitors are invokana, Jardiance, farxiga or forxiga, and suglat. Invokana refers to a prescription medication used to lower blood sugar levels in adults with type 2 diabetes. These medications are typically administered through the oral route and others and are used by end users such as hospitals, homecare settings, and clinics.

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Global Report 2026 Market Report bar graph

What Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size and Share 2026?

The sodium glucose cotransporter 2 (sglt2) inhibitors market size has grown strongly in recent years. It will grow from $10.96 billion in 2025 to $11.87 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising type 2 diabetes cases, unmet glycemic control needs, clinical trial success, physician awareness, regulatory approvals.

What Is The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Growth Forecast?

The sodium glucose cotransporter 2 (sglt2) inhibitors market size is expected to see strong growth in the next few years. It will grow to $16.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to cardio-renal benefit recognition, aging diabetic population, expanded reimbursement coverage, new drug launches, emerging market penetration. Major trends in the forecast period include expanded use beyond diabetes, increased combination therapy adoption, growth in heart failure indications, improved safety profiling, wider guideline inclusion.

Book your 30 minutes free consultation with our research experts

Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Segmentation

1) By Type: Invokana, Jardiance, Farxiga Or Forxiga, Suglat

2) By Route Of Administration: Oral Route, Other Route Of Administration

3) By End User: Hospitals, Homecare Settings, Clinics

Subsegments:

1) By Invokana: Generic Invokana (Canagliflozin), Branded Invokana

2) By Jardiance: Generic Jardiance (Empagliflozin), Branded Jardiance

3) By Farxiga Or Forxiga: Generic Farxiga (Dapagliflozin), Branded Farxiga

4) By Suglat: Suglat (Sotagliflozin) For Diabetes, Suglat (Sotagliflozin) For Heart Failure

What Is The Driver Of The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

The increasing prevalence of diabetes is expected to propel the growth of the sodium glucose cotransporter 2 (SGLT2) inhibitor market going forward. Diabetes refers to a group of metabolic disorders characterized by high blood sugar levels resulting from defects in insulin secretion, insulin action, or both. The rise in diabetes cases can be attributed to factors such as urbanization, stress, environmental pollutants, and a lack of access to healthcare services. Sodium glucose cotransporter 2 (SGLT2) inhibitors are used in diabetes treatment to lower blood glucose levels by preventing glucose reabsorption in the kidneys, leading to its excretion in urine. They also offer cardiovascular and renal benefits, making them a valuable option for managing diabetes and its complications. For instance, in March 2025, according to the Office for Health Improvement and Disparities (OHID), UK-Based English government organization, the prevalence of type 2 diabetes recorded by GPs among adults aged 17 and over in England was 7.0% in March 2024, up from 6.8% in March 2023. Therefore, the increasing prevalence of diabetes is driving the growth of the sodium glucose cotransporter 2 (SGLT2) inhibitor industry.

Key Players In The Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

Major companies operating in the sodium glucose cotransporter 2 (sglt2) inhibitors market are Johnson & Johnson Inc., Merck & Co Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma Inc, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co Ltd, Taisho Pharmaceutical Holdings Co Ltd, Lupin Limited, Glenmark Pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co Ltd, Kotobuki Pharmaceutical Co Ltd, Lexicon Pharmaceuticals Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Hanmi Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical Corp, Mitsubishi Tanabe Pharma Corporation

Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Trends and Insights

Major companies operating in the sodium glucose cotransporter 2 (SGLT2) inhibitor market are focused on developing dual inhibitor therapeutic solutions to improve patient outcomes and manage blood sugar levels. Dual inhibitor therapeutic solutions refer to treatments that simultaneously target two different sodium-glucose cotransporters (SGLT1 and SGLT2) to enhance efficacy in managing conditions such as heart failure and diabetes. For instance, in May 2023, Lexicon Pharmaceuticals Inc., a US-based biopharmaceutical company, received approval from the Food and Drug Administration (FDA) for sotagliflozin, a treatment for heart failure. This first-in-class dual inhibitor of sodium-glucose cotransporters 1 and 2 is a once-daily tablet designed to reduce cardiovascular death, heart failure hospitalizations, and urgent heart failure visits in adults with heart failure, type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors. Its benefits include reduced renal glucose and sodium reabsorption, which leads to preload and afterload reduction and decreased sympathetic activity.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

In October 2024, Viatris Inc., a US-based global healthcare company, entered into an exclusive licensing agreement with Lexicon Pharmaceuticals to commercialize sotagliflozin in all markets outside of the U.S. and Europe. The collaboration aims to expand access to sotagliflozin, enhance treatment options for patients with diabetes, and foster innovation in the global diabetes therapeutics market. Lexicon Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of novel therapies for metabolic diseases.

Regional Outlook

North America was the largest region in the sodium glucose cotransporter 2 (SGLT2) inhibitors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

The sodium glucose cotransporter 2 (SGLT2) inhibitors market consists of sales of luseogliflozin, remogliflozin, tofogliflozin and sergliflozin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report 2026?

The sodium glucose cotransporter 2 (sglt2) inhibitors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sodium glucose cotransporter 2 (sglt2) inhibitors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$11.87 billion
Revenue Forecast In 2035	$16.35 billion
Growth Rate	CAGR of 8.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Route Of Administration, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Johnson & Johnson Inc., Merck & Co Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma Inc, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co Ltd, Taisho Pharmaceutical Holdings Co Ltd, Lupin Limited, Glenmark Pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co Ltd, Kotobuki Pharmaceutical Co Ltd, Lexicon Pharmaceuticals Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Hanmi Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical Corp, Mitsubishi Tanabe Pharma Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expanded Use Beyond Diabetes

4.2.2 Increased Combination Therapy Adoption

4.2.3 Growth In Heart Failure Indications

4.2.4 Improved Safety Profiling

4.2.5 Wider Guideline Inclusion

5. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diabetes Clinics

5.3 Pharmacies

5.4 Specialty Clinics

5.5 Rehabilitation Centers

6. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size, Comparisons And Growth Rate Analysis

7.3. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Segmentation

9.1. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Invokana, Jardiance, Farxiga Or Forxiga, Suglat

9.2. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Route, Other Route Of Administration

9.3. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare Settings, Clinics

9.4. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Invokana, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Generic Invokana (Canagliflozin), Branded Invokana

9.5. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Jardiance, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Generic Jardiance (Empagliflozin), Branded Jardiance

9.6. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Farxiga Or Forxiga, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Generic Farxiga (Dapagliflozin), Branded Farxiga

9.7. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Suglat, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Suglat (Sotagliflozin) For Diabetes, Suglat (Sotagliflozin) For Heart Failure

10. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Regional And Country Analysis

10.1. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

11.1. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

12.1. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

13.1. India Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

14.1. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

14.2. Japan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

15.1. Australia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

16.1. Indonesia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

17.1. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

17.2. South Korea Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

18.1. Taiwan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

18.2. Taiwan Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

19.1. South East Asia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

19.2. South East Asia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

20.1. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

20.2. Western Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

21.1. UK Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

22.1. Germany Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

23.1. France Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

24.1. Italy Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

25.1. Spain Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

26.1. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

26.2. Eastern Europe Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

27.1. Russia Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

28.1. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

28.2. North America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

29.1. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

29.2. USA Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

30.1. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

30.2. Canada Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

31.1. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

31.2. South America Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

32.1. Brazil Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

33.1. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

33.2. Middle East Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

34.1. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Overview

34.2. Africa Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Regulatory and Investment Landscape

36. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Competitive Landscape And Company Profiles

36.1. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Company Profiles

36.3.1. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Other Major And Innovative Companies

Boehringer Ingelheim International GmbH, Astellas Pharma Inc, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co Ltd, Taisho Pharmaceutical Holdings Co Ltd, Lupin Limited, Glenmark Pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co Ltd, Kotobuki Pharmaceutical Co Ltd, Lexicon Pharmaceuticals Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Hanmi Pharmaceutical Co Ltd

38. Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market

40. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market High Potential Countries, Segments and Strategies

40.1 Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market In 2030 - Countries Offering Most New Opportunities

40.2 Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market In 2030 - Segments Offering Most New Opportunities

40.3 Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Overview Of Key Products - Product Examples

Table 2: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Supply Chain Analysis

Table 4: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Raw Material Providers

Table 5: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Resource Providers

Table 6: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Manufacturers (Suppliers)

Table 7: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Distributors And Channel Partners

Table 8: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Key Technologies & Future Trends

Table 9: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Trends

Table 10: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major End Users

Table 11: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - TAM, US$ Billion, 2025

Table 15: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Invokana, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Jardiance, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Farxiga Or Forxiga, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Suglat, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - Company Scoring Matrix

Table 98: Johnson & Johnson Inc. Financial Performance

Table 99: Merck & Co Inc. Financial Performance

Table 100: Bristol-Myers Squibb Company Financial Performance

Table 101: AstraZeneca plc Financial Performance

Table 102: Eli Lilly and Company Financial Performance

Table 103: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Competitive Dashboard

Table 105: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 108: Global, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

Figure 1: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Overview Of Key Products - Product Examples

Figure 2: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Supply Chain Analysis

Figure 4: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Raw Material Providers

Figure 5: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Resource Providers

Figure 6: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Manufacturers (Suppliers)

Figure 7: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Distributors And Channel Partners

Figure 8: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Key Technologies & Future Trends

Figure 9: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major Trends

Figure 10: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Major End Users

Figure 11: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - TAM, US$ Billion, 2025

Figure 15: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Invokana, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Jardiance, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Farxiga Or Forxiga, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Sub-Segmentation Of Suglat, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market - Company Scoring Matrix

Figure 98: Johnson & Johnson Inc. Financial Performance

Figure 99: Merck & Co Inc. Financial Performance

Figure 100: Bristol-Myers Squibb Company Financial Performance

Figure 101: AstraZeneca plc Financial Performance

Figure 102: Eli Lilly and Company Financial Performance

Figure 103: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market, Competitive Dashboard

Figure 105: Global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 108: Global, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Antidiabetics Market Report 2026 - Global Outlook – By Drug Class (Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes), By Diabetes Type (Type 1, Type 2), By Patient Population (Ant...

mTOR Inhibitors Market Report 2026 - Global Outlook – By Product Type (Rapamune, Afinitor, Torisel, Zortress, Other Product Types), By Indication (Oncology, Immunosuppressant, Organ Transplantation, Other Indications), B...

Kinase Inhibitors Market Report 2026 - Global Outlook – By Type (Tyrosine Kinase Inhibitors, Multikinase Inhibitors, mTOR Kinase Inhibitors, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By A...

ACE Inhibitors Market Report 2026 - Global Outlook – By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril...

Type 2 Diabetes Market Report 2026 - Global Outlook – By Drug Class (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfony...

Enzyme Inhibitor Market Report 2026 - Global Outlook – By Type (Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Sta...

Glucose Market Report 2026 - Global Outlook – By Form (Syrup, Solid), By Source (Wheat, Corn, Other Sources), By Application (Food and Beverage, Pharmaceutical, Cosmetics, Personal Care, Pulp and Paper, Other Application...

Frequently Asked Questions

How big is the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors Market?

The Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market was valued at $10.96 billion in 2025, increased to $11.87 billion in 2026, and is projected to reach $16.35 billion by 2030.

What is the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market growth?

The global Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market is expected to grow at a CAGR of 8.3% from 2026 to 2035 to reach $16.35 billion by 2035.

Who are the key players in Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

Some Key Players in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market Include, Johnson & Johnson Inc., Merck & Co Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Astellas Pharma Inc, Sun Pharmaceutical Industries Ltd, Sumitomo Dainippon Pharma Co Ltd, Taisho Pharmaceutical Holdings Co Ltd, Lupin Limited, Glenmark Pharmaceuticals, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Kissei Pharmaceutical Co Ltd, Kotobuki Pharmaceutical Co Ltd, Lexicon Pharmaceuticals Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Hanmi Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical Corp, Mitsubishi Tanabe Pharma Corporation .

What is the anticipated growth trend for the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

Major trend in this market includes: Innovations In SGLT2 Inhibitors For Enhanced Diabetes And Heart Failure Management. For further insights on this market. request a sample here

Which region has the most growth potential in the Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors market?

North America was the largest region in the sodium glucose cotransporter 2 (SGLT2) inhibitors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sodium glucose cotransporter 2 (sglt2) inhibitors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.